Achalasia is a primary motility disorder of the esophagus characterized by aperistalsis in the distal two thirds of the body and abnormal lower esophageal relaxation with swallows. Esophageal cancer has been reported in patients with achalasia and esophageal squamous cell carcinoma commoner than adenocarcinoma. Patients with achalasia estimatedly have a 33 times higher likelihood of developing esophageal cancer than general population. The disease manifests more than two decades after onset of achasia symptoms. Proposed mechanisms adduced to the malignant transformation in achalasia include food stasis, bacterial overgrowth, chronic inflammation, mucosal irritation leading to dysplastic changes and malignant transformation. Esophageal myoto...
Maura Torres-Aguilera,1 José María Remes Troche2 1Department of Pediatric Gastroenteri...
Esophageal achalasia is a disorder of the lower esophageal sphincter muscle. Patients present with d...
Background: Per oral endoscopic myotomy (POEM) has been reported to be a new therapeutic option for ...
We report a case of carcinoma of the esophagus in a 58 years old woman with achalasia, who has been ...
Achalasia is a rare neurological deficit of the esoph-agus that produces an impaired relaxation of t...
The development of Esophageal carcinoma with achalasia long after adequate surgical treatment is a r...
SummaryAchalasia is a rare motility disorder of the oesophagus characterised by loss of enteric neur...
Between 1980 and 1988, we treated 1,521 patients with squamous cell carcinoma of the esophagus and ...
Achalasia is characterized by impaired LES relaxation and by the lack of peristalsis in the distal e...
Achalasia is a rare neurological deficit of the esophagus that produces an impaired relaxation of th...
textabstractAchalasia is a rare motility disorder of the esophagus with evidence for an auto-immune ...
Between 1980 and 1988, we treated 1,521 patients with squamous cell carcinoma of the esophagus and 3...
Achalasia is a primary esophageal motility disorder with an estimated annual incidence of 1 per 100,...
Abstract Background Esophageal achalasia causes dysphagia following impaired relaxation of the lower...
SummaryAchalasia is a rare motility disorder of the oesophagus characterised by loss of enteric neur...
Maura Torres-Aguilera,1 José María Remes Troche2 1Department of Pediatric Gastroenteri...
Esophageal achalasia is a disorder of the lower esophageal sphincter muscle. Patients present with d...
Background: Per oral endoscopic myotomy (POEM) has been reported to be a new therapeutic option for ...
We report a case of carcinoma of the esophagus in a 58 years old woman with achalasia, who has been ...
Achalasia is a rare neurological deficit of the esoph-agus that produces an impaired relaxation of t...
The development of Esophageal carcinoma with achalasia long after adequate surgical treatment is a r...
SummaryAchalasia is a rare motility disorder of the oesophagus characterised by loss of enteric neur...
Between 1980 and 1988, we treated 1,521 patients with squamous cell carcinoma of the esophagus and ...
Achalasia is characterized by impaired LES relaxation and by the lack of peristalsis in the distal e...
Achalasia is a rare neurological deficit of the esophagus that produces an impaired relaxation of th...
textabstractAchalasia is a rare motility disorder of the esophagus with evidence for an auto-immune ...
Between 1980 and 1988, we treated 1,521 patients with squamous cell carcinoma of the esophagus and 3...
Achalasia is a primary esophageal motility disorder with an estimated annual incidence of 1 per 100,...
Abstract Background Esophageal achalasia causes dysphagia following impaired relaxation of the lower...
SummaryAchalasia is a rare motility disorder of the oesophagus characterised by loss of enteric neur...
Maura Torres-Aguilera,1 José María Remes Troche2 1Department of Pediatric Gastroenteri...
Esophageal achalasia is a disorder of the lower esophageal sphincter muscle. Patients present with d...
Background: Per oral endoscopic myotomy (POEM) has been reported to be a new therapeutic option for ...